| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.16 | 0.006 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.007 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.008 |
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.095 | 0.02 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |